Special Issue "Precision Delivery of Drugs and Imaging Agents with Peptides"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".

Deadline for manuscript submissions: 31 January 2021.

Special Issue Editors

Prof. Dr. Tambet Teesalu
Guest Editor
Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 14b, 50411 Tartu, Estonia
Interests: affinity targeting; nanomedicine; in vivo peptide phage display; tumor-homing peptides; tumor-penetrating peptides; iRGD; neuropilin-1; tumor-assciated macrophages
Dr. Kaido Kurrikoff
Website1 Website2
Co-Guest Editor
Institute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia
Interests: CPP; cell-penetrating peptides; drug delivery systems; transfection reagents; gene therapy; molecular diagnostics; isothermal nucleic acid amplification

Special Issue Information

Dear Colleagues,

Systemic targeting of vascular ZIP codes with homing peptides is an increasingly recognized strategy that can be used to improve the biodistribution profile and to increase potency of drugs. Another class of transport peptides, cell-penetrating peptides (CPP), are widely used to trigger robust intracellular uptake of molecular and nanoscale payloads. Peptides have several advantages over other classes of affinity ligands, including a small size (and thus improved tissue penetration, straightforward synthesis, and low cost), low immunogenicity, and biocompatibility.

This Special Issue will provide insights into peptide-based precision targeting from top experts from around the world. Original research and reviews in the issue summarize preclinical and clinical applications of peptide-based targeting for delivery of molecular and nanoscale diagnostic and therapeutic payloads in the context of cancer, cardiovascular and pulmonary diseases, and regenerative medicine.

Prof. Dr. Tambet Teesalu
Dr. Kaido Kurrikoff
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • peptide
  • tumor-penetrating peptide
  • cell-penetrating peptide
  • cancer
  • regenerative medicine
  • cardiovascular disease
  • molecular imaging
  • precision therapy

Published Papers

This special issue is now open for submission.
Back to TopTop